Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Álvarez-Larrán, Alberto
192  Ergebnisse:
Personensuche X
?
1

Genomic classification and outcomes of young patients with ..:

Garrote, Marta ; López-Guerra, Mónica ; García-Pagán, Juan Carlos...
Annals of Hematology.  103 (2024)  3 - p. 737-747 , 2024
Link: https://doi.org/10.1007/..
 
?
2

ROP-ET: a prospective phase III trial investigating the eff..:

Kiladjian, Jean-Jacques ; Marin, Francisca Ferrer ; Al-Ali, Haifa Kathrin...
Annals of Hematology.  103 (2024)  7 - p. 2299-2310 , 2024
Link: https://doi.org/10.1007/..
 
?
3

DNMT3A/TET2/ASXL1 Mutations are an Age-independent Thrombot..:

Segura-Díaz, Adrián ; Stuckey, Ruth ; Florido, Yanira...
Thrombosis and Haemostasis.  124 (2024)  7 - p. 669-675 , 2024
Link: https://doi.org/10.1055/..
 
?
4

Application of IPSET-thrombosis in 1366 Patients Prospectiv..:

Alvarez-Larrán, Alberto ; Cuevas, Beatriz ; Velez, Patricia...
HemaSphere.  7 (2023)  8 - p. e936 , 2023
Link: https://doi.org/10.1097/..
 
?
5

Toxicity of Asciminib in Real Clinical Practice: Analysis o..:

Pérez-Lamas, Lucía ; Luna, Alejandro ; Boque, Concepción...
Cancers.  15 (2023)  4 - p. 1045 , 2023
Link: https://doi.org/10.3390/..
 
?
6

Should we move to a genomic classification of neutrophilic ..:

Carreño-Tarragona, Gonzalo ; Álvarez-Larrán, Alberto ; Hernández-Boluda, Juan Carlos..
Blood Advances.  7 (2023)  21 - p. 6705-6706 , 2023
Link: https://doi.org/10.1182/..
 
?
7

Cytogenetic Assessment and Risk Stratification in Myelofibr..:

Díaz-González, Álvaro ; Mora, Elvira ; Avetisyan, Gayane...
Cancers.  15 (2023)  11 - p. 3039 , 2023
Link: https://doi.org/10.3390/..
 
?
8

Clinical Characteristics and Outcomes of Patients with Prim..:

Garrote, Marta ; López-Guerra, Mónica ; Arellano-Rodrigo, Eduardo...
Cancers.  15 (2023)  15 - p. 3904 , 2023
Link: https://doi.org/10.3390/..
 
?
9

Machine Learning Improves Risk Stratification in Myelofibro..:

Mosquera-Orgueira, Adrián ; Pérez-Encinas, Manuel ; Hernández-Sánchez, Alberto...
HemaSphere.  7 (2023)  1 - p. e818 , 2023
Link: https://doi.org/10.1097/..
 
?
10

Ropeginterferon phase 2 randomized study in low-risk polycy..:

Barbui, Tiziano ; Carobbio, Alessandra ; De Stefano, Valerio...
Annals of Hematology.  103 (2023)  2 - p. 437-442 , 2023
Link: https://doi.org/10.1007/..
 
?
11

CNL and aCML should be considered as a single entity based ..:

Carreño-Tarragona, Gonzalo ; Álvarez-Larrán, Alberto ; Harrison, Claire...
Blood Advances.  7 (2023)  9 - p. 1672-1681 , 2023
Link: https://doi.org/10.1182/..
 
?
12

Low-risk polycythemia vera treated with phlebotomies: clini..:

Triguero, Ana ; Pedraza, Alexandra ; Pérez-Encinas, Manuel...
Annals of Hematology.  101 (2022)  10 - p. 2231-2239 , 2022
Link: https://doi.org/10.1007/..
 
?
13

Phase III MANIFEST-2: Pelabresib + Ruxolitinib vs Placebo +..:

Harrison, Claire N ; Gupta, Vikas K ; Gerds, Aaron T...
Future Oncology.  18 (2022)  27 - p. 2987-2997 , 2022
Link: https://doi.org/10.2217/..
 
?
14

Second versus first wave of COVID-19 in patients with MPN:

Barbui, Tiziano ; Iurlo, Alessandra ; Masciulli, Arianna...
Leukemia.  36 (2022)  3 - p. 897-900 , 2022
Link: https://doi.org/10.1038/..
 
?
15

Breakthrough infections in MPN-COVID vaccinated patients:

Barbui, Tiziano ; Carobbio, Alessandra ; Ghirardi, Arianna...
Blood Cancer Journal.  12 (2022)  11 - p. , 2022
Link: https://doi.org/10.1038/..
 
1-15